Anna Schappert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anna Schappert has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Davenport
Department of Renal Medicine, Royal Free Hospital, Division of Medicine, University College London, London, UK
1 shared publication Claudia Barth
Medical Scientific Affairs, B.Braun Avitum, Melsungen, Germany
1 shared publication- Dominik Bergis
Diabetes Center Mergentheim, Diabetes Clinic, Bad Mergentheim, Germany
1 shared publication - Felix Fischer
Department for Psychosomatic Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
1 shared publication Giovanni F.M. Strippoli
Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia
1 shared publication- Gregor Liegl
Department of Psychosomatic Medicine, Center for Patient-Centered Outcome Research, Charité – University Medical Center Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
1 shared publication
Latest Publications
- Open Access
- 2 October 2024
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (1) , 76-85
Psychosocial Determinants for Self-Reported Health Status in Patients on Hemodialysis
Key Points: Health-related quality of life in dialysis depends on many nonclinical factors. Psychosocial determinants contribute to explaining variance in health-related quality-of-life domains better than demographic and medical variables alone. In comparison with past small-scale studies, self-efficacy showed significant associations with all aspects of health-related quality of life. Background: We investigated whether psychosocial determinants self-efficacy and social support are associated with health-related quality of life in patients on hemodialysis enrolled in the CONVINCE trial. Methods: We used baseline data from the cohort of patients involved in the CONVINCE randomized trial of hemodiafiltration versus hemodialysis. Measures included age, sex, relationship status, children, housing, education, employment, comorbidities, dialysis schedules, time of first dialysis, residual kidney function, general self-efficacy and social support scores, and Patient-Reported Outcomes Measurement Information System measurements for health-related quality of life. Associations were analyzed using hierarchical regression. Results: One thousand three hundred sixty patients from the CONVINCE trial were the cohort of interest. The mean age was 62±13.5 years (range, 20–92), and 66.9% were male. Self-efficacy was a significant predictor for all health-related quality-of-life domains: depression (β=−0.36, P < 0.001), anxiety (β=−0.35, P < 0.001), social participation (β=0.32, P < 0.001), cognition (β=0.29, P < 0.001), fatigue (β=−0.29, P < 0.001), physical function (β=0.27, P < 0.001), sleep disturbance (β=−0.23, P < 0.001), pain interference (β=0.21, P < 0.001), pain intensity (β=−0.17, P < 0.001), interdialytic symptoms (β=−0.14, P = 0.002), and intradialytic symptoms (β=−0.14, P = 0.002). Social support was a significant predictor for cognition (β=0.21, P < 0.001), sleep disturbance (β=−0.11, P = 0.017), and intradialytic symptoms (β=−0.11, P = 0.02). Conclusions: Higher general self-efficacy scale scores are associated with improvements in cognition, depression, anxiety, social participation, fatigue, physical function, sleep disturbance, pain interference, interdialytic symptoms, pain intensity, and intradialytic symptoms. Associations for self-efficacy are larger than those for social support and stronger than previously reported. It is plausible that targeted psychosocial interventions may improve health outcomes in people on hemodialysis. Podcast: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/K360/2025_01_30_KID0000000599.mp3
- 2 October 2024
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (1) , 76-85
Open AccessPsychosocial Determinants for Self-Reported Health Status in Patients on Hemodialysis
Key Points: Health-related quality of life in dialysis depends on many nonclinical factors. Psychosocial determinants contribute to explaining variance in health-related quality-of-life domains better than demographic and medical variables alone. In comparison with past small-scale studies, self-efficacy showed significant associations with all aspects of health-related quality of life. Background: We investigated whether psychosocial determinants self-efficacy and social support are associated with health-related quality of life in patients on hemodialysis enrolled in the CONVINCE trial. Methods: We used baseline data from the cohort of patients involved in the CONVINCE randomized trial of hemodiafiltration versus hemodialysis. Measures included age, sex, relationship status, children, housing, education, employment, comorbidities, dialysis schedules, time of first dialysis, residual kidney function, general self-efficacy and social support scores, and Patient-Reported Outcomes Measurement Information System measurements for health-related quality of life. Associations were analyzed using hierarchical regression. Results: One thousand three hundred sixty patients from the CONVINCE trial were the cohort of interest. The mean age was 62±13.5 years (range, 20–92), and 66.9% were male. Self-efficacy was a significant predictor for all health-related quality-of-life domains: depression (β=−0.36, P < 0.001), anxiety (β=−0.35, P < 0.001), social participation (β=0.32, P < 0.001), cognition (β=0.29, P < 0.001), fatigue (β=−0.29, P < 0.001), physical function (β=0.27, P < 0.001), sleep disturbance (β=−0.23, P < 0.001), pain interference (β=0.21, P < 0.001), pain intensity (β=−0.17, P < 0.001), interdialytic symptoms (β=−0.14, P = 0.002), and intradialytic symptoms (β=−0.14, P = 0.002). Social support was a significant predictor for cognition (β=0.21, P < 0.001), sleep disturbance (β=−0.11, P = 0.017), and intradialytic symptoms (β=−0.11, P = 0.02). Conclusions: Higher general self-efficacy scale scores are associated with improvements in cognition, depression, anxiety, social participation, fatigue, physical function, sleep disturbance, pain interference, interdialytic symptoms, pain intensity, and intradialytic symptoms. Associations for self-efficacy are larger than those for social support and stronger than previously reported. It is plausible that targeted psychosocial interventions may improve health outcomes in people on hemodialysis. Podcast: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/K360/2025_01_30_KID0000000599.mp3
- 29 June 2016
- Published by Springer Nature in Der Diabetologe
- Vol. 12 (5) , 352-357
Histiozytär nekrotisierende Lymphadenitis
- 29 June 2016
- Published by Springer Nature in Der Diabetologe
- Vol. 12 (5) , 352-357
Histiozytär nekrotisierende Lymphadenitis